CCCC
Price
$2.06
Change
-$0.10 (-4.63%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
145.88M
57 days until earnings call
SVRA
Price
$2.54
Change
-$0.12 (-4.51%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
437.63M
One day until earnings call
Ad is loading...

CCCC vs SVRA

Header iconCCCC vs SVRA Comparison
Open Charts CCCC vs SVRABanner chart's image
C4 Therapeutics
Price$2.06
Change-$0.10 (-4.63%)
Volume$64.99K
Capitalization145.88M
Savara
Price$2.54
Change-$0.12 (-4.51%)
Volume$12.8K
Capitalization437.63M
CCCC vs SVRA Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. SVRA commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and SVRA is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CCCC: $2.15 vs. SVRA: $2.65)
Brand notoriety: CCCC and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 38% vs. SVRA: 75%
Market capitalization -- CCCC: $145.88M vs. SVRA: $437.63M
CCCC [@Biotechnology] is valued at $145.88M. SVRA’s [@Biotechnology] market capitalization is $437.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while SVRA’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 3 bearish.
  • SVRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -10.42% price change this week, while SVRA (@Biotechnology) price change was +14.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

CCCC is expected to report earnings on May 08, 2025.

SVRA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($438M) has a higher market cap than CCCC($146M). SVRA YTD gains are higher at: -13.518 vs. CCCC (-40.278). SVRA has higher annual earnings (EBITDA): -88.58M vs. CCCC (-103.45M). CCCC has more cash in the bank: 256M vs. SVRA (219M). SVRA has less debt than CCCC: SVRA (26.7M) vs CCCC (67.1M). CCCC has higher revenues than SVRA: CCCC (33.7M) vs SVRA (0).
CCCCSVRACCCC / SVRA
Capitalization146M438M33%
EBITDA-103.45M-88.58M117%
Gain YTD-40.278-13.518298%
P/E RatioN/AN/A-
Revenue33.7M0-
Total Cash256M219M117%
Total Debt67.1M26.7M251%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCSVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAGVX45.34N/A
N/A
BNY Mellon Dynamic Value Fund A
TSONX14.23N/A
N/A
Nuveen International Res Eq R6
MADSX23.45N/A
N/A
Morgan Stanley Inst Advantage R6
EQNSX21.51N/A
N/A
MFS Equity Income R2
DSCIX12.71N/A
N/A
Dana Epiphany Small Cap Eq Instl

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-8.90%
KYMR - CCCC
59%
Loosely correlated
+0.40%
PRME - CCCC
49%
Loosely correlated
-13.33%
FATE - CCCC
49%
Loosely correlated
-8.24%
IMNM - CCCC
48%
Loosely correlated
-5.14%
CRBU - CCCC
48%
Loosely correlated
-5.17%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+2.12%
LRMR - SVRA
47%
Loosely correlated
-4.95%
ATXS - SVRA
43%
Loosely correlated
-5.82%
KYMR - SVRA
41%
Loosely correlated
+0.40%
SLNO - SVRA
41%
Loosely correlated
-2.46%
CCCC - SVRA
39%
Loosely correlated
-8.90%
More